TP53 and malignant colon neoplasm: Using colon cancer organoids carrying mutations in Apc, Kras and Tp53 genes, we showed here that Dkk2 knockout disrupted Lysozyme (LYZ) positive cell formation in colon cancer organoids as well as metastatic nodules in vivo.